Key Segmentation
By Drug Type
-
Glimepiride
-
Glipizide
-
Glyburide (Glibenclamide)
-
Gliclazide
-
Gliquidone
-
Others
By Drug Generation
-
First-Generation Sulfonylureas
-
Second-Generation Sulfonylureas
By Indication
-
Type 2 Diabetes Mellitus
-
Metabolic Syndrome
-
Others
By Dosage Form
-
Tablets
-
Capsules
-
Oral Suspension
-
Others
By Distribution Channel
-
Hospital Pharmacies
-
Retail Pharmacies
-
Online Pharmacies
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Ans: The Sulfonylureas Market is projected to grow at a CAGR of 3.20% during 2026–2035.
Ans: The market is valued at USD 8.89 Billion in 2025 and is projected to reach USD 12.16 Billion by 2035.
Ans: Growth is driven by rising type 2 diabetes prevalence, demand for cost-effective oral therapies, expanding healthcare access, and increasing adoption of combination diabetes treatments.
Ans: By Drug Type, Glimepiride dominated with a 28.47% share, while Gliclazide is projected to grow at the fastest CAGR of 7.26% during 2026–2035.
Ans: North America dominated with a 38.72% share in 2025, while Asia-Pacific is the fastest-growing region, expected to expand at a CAGR of 4.98% during 2026–2035.